Sequent Scientific Limited (SEQUENT.NS)
INR 180.0
(-1.51%)
INR 180.0
(-1.51%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -141.38 Million | 168.08 Million | 305.95 Million | 1.14 Billion | 1.15 Billion | 1.16 Billion |
| Net Income | -358.69 Million | -1.37 Billion | 533.86 Million | 1.45 Billion | 940.75 Million | 588.84 Million |
| Depreciation & Amortization | 615.4 Million | 556.93 Million | 510.85 Million | 505.98 Million | 506.22 Million | 419.2 Million |
| Deferred income taxes | - | -41.79 Million | -330.24 Million | -398.98 Million | -99.48 Million | 86.14 Million |
| Stock-based compensation | 222.28 Million | 354.11 Million | 333.01 Million | 72.34 Million | 46.67 Million | 30.93 Million |
| Change in working capital | -456.32 Million | -516.13 Million | -892.97 Million | -708.86 Million | -582.97 Million | -279.44 Million |
| Other non-cash items | 1.74 Billion | 1.19 Billion | 151.44 Million | 222.54 Million | 342.11 Million | 314.57 Million |
| Investing Cash Flow | -64.93 Million | -649.58 Million | -955.66 Million | 96.48 Million | -722.7 Million | -676.95 Million |
| Investments in PPE | -308.07 Million | -861.79 Million | -324.64 Million | -528.3 Million | -407.22 Million | -254.45 Million |
| Acquisitions | 191.52 Million | -154.4 Million | -684.67 Million | -1.4 Billion | 389.7 Million | -690.56 Million |
| Investment purchases | -82.23 Million | -83.16 Million | 647.19 Million | -1.4 Billion | -390.07 Million | -44.97 Million |
| Sales/Maturities of investments | 59.85 Million | 237.56 Million | 37.48 Million | 1.93 Billion | 370 Thousand | 161.86 Million |
| Other Investing Activities | 74 Million | 212.21 Million | -631.02 Million | 1.5 Billion | -315.48 Million | 151.17 Million |
| Financing Cash Flow | 439.07 Million | 322.28 Million | 672.57 Million | -1.38 Billion | -427.53 Million | -200.84 Million |
| Debt repayment | -548.07 Million | -356.25 Million | -313.1 Million | -1.61 Billion | -849.05 Million | -1.02 Billion |
| Dividends payments | - | - | -123.44 Million | - | -58.26 Million | - |
| Common Stock Repurchased | - | - | 200.56 Million | - | 458.37 Million | - |
| Common Stock Issuance | - | - | 112.54 Million | 104.49 Million | 20.99 Million | 6.74 Million |
| Other Financing Activities | -760 Thousand | 678.53 Million | 796.01 Million | 126.27 Million | -9.28 Million | 821.97 Million |
| Accounts receivables | -87.82 Million | -412.64 Million | -407.24 Million | -394.75 Million | -508.17 Million | -9.65 Million |
| Accounts payables | -371.36 Million | -170.13 Million | 654.65 Million | 89.29 Million | 153.13 Million | -59.61 Million |
| Inventory | 2.86 Million | 50.79 Million | -1.14 Billion | -456.17 Million | -193.14 Million | -196.72 Million |
| Other working capital | -400 Thousand | 15.85 Million | 6.95 Million | 52.77 Million | -34.79 Million | -13.46 Million |
| Cash at beginning of period | 417.46 Million | 574.96 Million | 537.44 Million | 680.96 Million | 677.89 Million | 395.44 Million |
| Cash at end of period | 698.3 Million | 415.74 Million | 574.96 Million | 537.44 Million | 680.96 Million | 677.89 Million |
| Capital Expenditure | -308.07 Million | -861.79 Million | -324.64 Million | -528.3 Million | -407.22 Million | -254.45 Million |
| Effect of forex changes on cash | - | - | 14.66 Million | - | - | - |
| Net cash flow / Change in cash | 280.84 Million | -159.22 Million | 37.52 Million | -143.52 Million | 3.07 Million | 282.45 Million |
| Free Cash Flow | -449.45 Million | -693.71 Million | -18.69 Million | 619.24 Million | 746.08 Million | 905.79 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 65.09 Million | -358.69 Million | -9.11 Million | 82.68 Million | -83.8 Million | -348.46 Million |
| Depreciation & Amortization | - | 615.4 Million | - | 154.55 Million | 153.6 Million | 142.41 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 222.28 Million | 222.28 Million | - | - | - |
| Change in working capital | - | -456.32 Million | - | - | - | - |
| Other non-cash items | -65.09 Million | 1.74 Billion | -213.17 Million | -82.68 Million | 83.8 Million | 348.46 Million |
| Investing Cash Flow | - | -64.93 Million | - | - | - | - |
| Investments in PPE | - | -308.07 Million | - | - | - | - |
| Acquisitions | - | 191.52 Million | - | - | - | - |
| Investment purchases | - | -82.23 Million | - | - | - | - |
| Sales/Maturities of investments | - | 59.85 Million | - | - | - | - |
| Other Investing Activities | - | 74 Million | - | - | - | - |
| Financing Cash Flow | - | 439.07 Million | - | - | - | - |
| Debt repayment | - | -548.07 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -760 Thousand | - | - | - | - |
| Accounts receivables | - | -87.82 Million | - | - | - | - |
| Accounts payables | - | -371.36 Million | - | - | - | - |
| Inventory | - | 2.86 Million | - | - | - | - |
| Other working capital | - | -400 Thousand | - | - | - | - |
| Cash at beginning of period | - | 417.46 Million | - | 589.28 Million | 282.08 Million | 417.46 Million |
| Cash at end of period | - | 698.3 Million | - | 898.38 Million | 589.28 Million | 702.28 Million |
| Capital Expenditure | - | -308.07 Million | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 280.84 Million | - | 309.1 Million | 307.2 Million | 284.82 Million |
| Free Cash Flow | - | -449.45 Million | - | 309.1 Million | 307.2 Million | 284.82 Million |
HAN
ORKLY
ZENITHEXPO
JSWINFRA
4360
PSDNF